Ling Zhen, ClinChoice CEO

With Lil­ly's back­ing, a CRO with roots in Chi­na bags $150M round to fu­el glob­al growth

A re­named CRO with deep ties in the US and Chi­na has pulled in an­oth­er round of cap­i­tal.

Clin­Choice, for­mer­ly Foun­tain Med­ical De­vel­op­ment, has com­plet­ed a $150 mil­lion Se­ries E fund­ing round, us­ing the cash to con­tin­ue its planned ex­pan­sion.

Ac­cord­ing to Clin­Choice CEO Ling Zhen, the funds from the round will be part of a two-pronged strat­e­gy cen­tered around the com­pa­ny’s phys­i­cal growth. One area will be go­ing to­ward new so­lu­tions such as re­mote mon­i­tor­ing and da­ta an­a­lyt­ics but the oth­er area will be to­ward a ge­o­graph­ic ex­pan­sion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.